1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "36945-98-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-11062


    TRP Channel Cancer Neurological Disease
    Icilin (AG-3-5) is an agonist of nonselective cation channel TRPM8, with antiproliferative activity. Icilin activated currents only in wild type TRPM8 and in the presence of Ca 2+. Icilin can induce G1 arrest in prostate cancer cells.